Transfusion of donor peripheral blood buffy coat cells as effective treatment for relapsed acute leukemia after transplantation of allogeneic bone marrow or peripheral blood stem cells from the same donor

Transfusion

Volumn 36, Issue 8, 1996, Pages 685-690

  Tzeng, C H ^a,b   Lin, J S ^a,b   Lee, J C I ^c   Yung, C H ^a   Hu, H Y ^a   Chen, P M ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CENTRAL POLICE UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLOOD CELL; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOTHERAPY; MALE; POLYMERASE CHAIN REACTION; SCHOOL CHILD; TANDEM REPEAT; TREATMENT PLANNING;

EID: 0029759444     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36896374371.x     Document Type: Article

References (35)

1. Appelbaum FR, Fisher LD, Thomas ED. Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. Blood 1988;72:179-84.
2. Reiffers J, Gaspard MH, Maraninchi D, et al. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial. Br J Haematol 1989;72:57-63.
3. Zander AR, Keating M, Dicke K, et al. A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol 1988;6:1548-57.
4. Sokal JE. Evaluation of survival data for chronic myelocytic leukemia. Am J Hematol 1976;1:493-500.
5. Thomas ED, Clift RA. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989;73:861-4.
6. Barrett AJ, Horowitz MM, Gale RP, et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989;74:862-71.
7. Doney K, Fisher LD, Appelbaum FR, et al. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone Marrow Transplant 1991;7:453-9.
8. McGlave P. Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival. Semin Hematol 1990;27(3 Suppl 4):23-30.
9. Ozsahin M, Pene F, Touboul E, et al. Total-body irradiation before bone marrow transplantation. Results of two randomized instantaneous dose rates in 157 patients. Cancer 1992;69:2853-65.
10. Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 1979;300:1068-73.
11. Sullivan KM, Weiden PL, Storb R, et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989;73:1720-8.
12. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75:555-62.
13. Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988;108:806-14.
14. Marmont AM, Horowitz MM, Gale RP, et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991;78:2120-30.
15. Kolb HJ, Mittermüller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990;76:2462-5.
16. Cullis JO, Jiang YZ, Schwarer AP, et al. Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation (letter). Blood 1992;79:1379-81.
17. Bar BM, Schattenberg A, Mensink EJ, et al. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. J Clin Oncol 1993;11:513-9.
18. Kolb HJ, Mittermüller J, Hertenstein H, et al. Adoptive immunotherapy in human and canine chimeras - the role of interferon alfa. EMBT Chronic Leukemia Working Party. Semin Hematol 1993;30(Suppl 3):37-9.
19. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986;314:729-35.
20. Lee JC, Chang JG. ABO genotyping by polymerase chain reaction. J Forensic Sci 1992;37:1269-75.
21. Mullenbach R, Lagoda PJ, Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 1989;5:391.
22. Polymeropoulos MH, Rath DS, Xiao H, Merril CR. Tetranucleotide repeat polymorphism at the human c-fes/fps proto-oncogene (FES). Nucleic Acids Res 1991;19:4018.
23. Lee JCI. [PCR in forensic DNA analysis] (in Chinese). Taoyuan: Taiwan Central Police University Press, 1995:173-88.
24. n and reassignment of alleles in population analysis by using a locus-specific allelic ladder. Am J Hum Genet 1993;53:953-8.
25. Bassam BJ, Caetano-Anolles G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 1991;196:80-3.
26. Snyder DS. Management of relapse after bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Boston: Blackwell, 1994:545-55.
27. Bortin MM, Rimm AA, Saltzstein EC. Graft versus leukemia: quantification of adoptive immunotherapy in murine leukemia. Science 1973;179:811-3.
28. Fefer A, Einstein AB Jr, Cheever MA, Berenson JR. Models for syngeneic adoptive chemoimmunotherapy of murine leukemias. Ann N Y Acad Sci 1976;276:573-83.
29. Drobyski WR, Keever CA, Roth MS, et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993;82:2310-8.
30. Porter DL, Roth MS, McGarigle C, et al. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 1994;330:100-6.
31. Kumar L. Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 1994;12:1710-7.
32. Bar BM, Schattenberg A, Van Dijk BA, et al. Host and donor erythrocyte repopulation patterns after allogeneic bone marrow transplantation analysed with antibody-coated fluorescent microspheres. Br J Haematol 1989;72:239-45.
33. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-17.
34. Slavin S, Naparstek E, Nagler A, et al. Allogeneic cell-mediated immunotherapy of relapsed leukemia following bone marrow transplantation with donor peripheral blood lymphocytes and recombinant human interleukin-2 (abstract). Exp Hematol 1995;23:787.
35. Skorski T, Kawalec M, Kawiak J. Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide. Cancer Immunol Immunother 1990;32:71-4.